Kore Private Wealth’s Ultragenyx Pharmaceutical RARE Stock Holding History

Kore Private Wealth’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-250	Closed	-$19K	–	882
2020 Q2	$19K	Hold	250	–	–	﹤0.01%	657
2020 Q1	$11K	Hold	250	–	–	﹤0.01%	680
2019 Q4	$11K	Buy	+250	New	+$10.3K	﹤0.01%	728
2019 Q2	–	Sell	-250	Closed	-$17K	–	652
2019 Q1	$17K	Hold	250	–	–	﹤0.01%	532
2018 Q4	$11K	Buy	+250	New	+$13.7K	﹤0.01%	561

Other funds holding RARE

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return